- Home
- DAR vs RYTM Comparison
DAR vs RYTM Comparison
Compare DAR & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAR
- RYTM
- Stock Information
- Founded
- DAR 1882
- RYTM 2008
- Country
- DAR United States
- RYTM United States
- Employees
- DAR 15500
- RYTM N/A
- Industry
- DAR Packaged Foods
- RYTM Biotechnology: Pharmaceutical Preparations
- Sector
- DAR Consumer Staples
- RYTM Health Care
- Exchange
- DAR Nasdaq
- RYTM Nasdaq
- Market Cap
- DAR 5.5B
- RYTM 6.4B
- IPO Year
- DAR 1994
- RYTM 2017
- Fundamental
- Price
- DAR $33.47
- RYTM $113.89
- Analyst Decision
- DAR Strong Buy
- RYTM Strong Buy
- Analyst Count
- DAR 8
- RYTM 13
- Target Price
- DAR $46.50
- RYTM $110.38
- AVG Volume (30 Days)
- DAR 2.5M
- RYTM 527.9K
- Earning Date
- DAR 10-23-2025
- RYTM 11-04-2025
- Dividend Yield
- DAR N/A
- RYTM N/A
- EPS Growth
- DAR N/A
- RYTM N/A
- EPS
- DAR 0.67
- RYTM N/A
- Revenue
- DAR $5,843,771,000.00
- RYTM $156,287,000.00
- Revenue This Year
- DAR $4.21
- RYTM $46.53
- Revenue Next Year
- DAR $4.92
- RYTM $61.83
- P/E Ratio
- DAR $50.20
- RYTM N/A
- Revenue Growth
- DAR N/A
- RYTM 53.55
- 52 Week Low
- DAR $26.00
- RYTM $45.91
- 52 Week High
- DAR $43.49
- RYTM $115.12
- Technical
- Relative Strength Index (RSI)
- DAR 60.22
- RYTM 66.07
- Support Level
- DAR $33.21
- RYTM $105.40
- Resistance Level
- DAR $35.22
- RYTM $115.12
- Average True Range (ATR)
- DAR 1.39
- RYTM 4.28
- MACD
- DAR 0.37
- RYTM 0.48
- Stochastic Oscillator
- DAR 79.97
- RYTM 86.15
About DAR Darling Ingredients Inc.
Darling Ingredients Inc develops and manufactures sustainable ingredients for customers in the pharmaceutical, food, pet food, fuel, and fertilizer industries. It collects and transforms all aspects of animal by-product streams into ingredients, including gelatin, fats, proteins, pet food ingredients, fertilizers. Also, the company recovers and converts used cooking oil and bakery remnants into feed and fuel ingredients. Darling has three primary business segments which are feed ingredients contributing the majority of revenue, food ingredients, and fuel ingredients. It provides grease trap services for food businesses and sells various equipment for collecting and delivering cooking oil. The company derives the majority of its revenue from customers in North America.
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.